What To Expect From J&J’s Full Year 2015 Earnings Announcement?

+13.65%
Upside
158
Market
180
Trefis
JNJ: Johnson & Johnson logo
JNJ
Johnson & Johnson

Where are we in relation to company guidance and consensus, as we approach the fourth-quarter and full-year earnings report? How will macroeconomic and currency effects be evident in the results, in relation to underlying business and product pipeline trends?

Here is what we expect from J&J’s full year 2015 earnings results. 

See how we provide complex answers to hard questions with these direct and schematic responses.
J&J_Q12_4

Relevant Articles
  1. Will Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs of $185?
  2. Should You Pick Johnson & Johnson Stock At $160?
  3. Should You Pick Johnson & Johnson Stock After A 6% Fall In A Month Despite Upbeat Q3?
  4. What’s Happening With Johnson & Johnson Stock?
  5. Johnson & Johnson Poised For A Muted Q2?
  6. Cross-Sector Comparison: Is Caterpillar Stock A Better Pick Over J&J?

 

J&J_Q12_1

JNJ_Question12_2

J&J_Q12_3

Sources:

http://www.pharmatimes.com/Article/11-10-20/Diabetes_type_2_drug_market_to_nearly_double_by_2020.aspx

http://www.reuters.com/article/us-genmab-stocks-idUSKBN0L816E20150204

http://www.usitc.gov/publications/332/Torsekar_MedicalDeviceExportstoChina_FINAL.pdf

Have more questions about Johnson & Johnson? See the links below.

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our complete analysis for Johnson & Johnson

See More at Trefis | View Interactive Institutional Research (Powered by Trefis)

Get Trefis Technology